{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T01:38:58Z","timestamp":1788745138884,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24fk0210122h0002"],"award-info":[{"award-number":["24fk0210122h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-024-00299-1","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T13:02:45Z","timestamp":1725973365000},"page":"677-689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Prevalence and Genotype Distribution of Hepatitis C Virus in Kenya: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"14","author":[{"given":"Grace Naswa","family":"Makokha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huarui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Nelson","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maidina","family":"Abuduwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elijah","family":"Songok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hijikata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"299_CR1","doi-asserted-by":"publisher","unstructured":"Mafirakureva N et al. Feb., Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan. J Viral Hepat. 2021;28(2):268\u2013278. https:\/\/doi.org\/10.1111\/JVH.13422","DOI":"10.1111\/JVH.13422"},{"key":"299_CR2","doi-asserted-by":"publisher","unstructured":"Stasi C, Silvestri C, Voller F. Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination. SN Compr Clin Med. 2020;2(12):2808\u20132815. https:\/\/doi.org\/10.1007\/S42399-020-00588-3","DOI":"10.1007\/S42399-020-00588-3"},{"key":"299_CR3","unstructured":"Global Hepatitis Programme. Accessed: Mar. 05, 2024. [Online]. Available: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hepatitis\/strategic-information"},{"key":"299_CR4","unstructured":"Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis. Accessed: Mar. 05, 2024. [Online]. Available: https:\/\/www.who.int\/publications\/i\/item\/WHO-HIV-2016.06"},{"key":"299_CR5","doi-asserted-by":"publisher","unstructured":"Karoney MJ, Siika AM. Hepatitis C virus (HCV) infection in Africa: a review. Pan Afr Med J. 2013;14. https:\/\/doi.org\/10.11604\/PAMJ.2013.14.44.2199.","DOI":"10.11604\/PAMJ.2013.14.44.2199"},{"key":"299_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s2468-1253(23)00408-9","volume":"9","author":"K Heath","year":"2024","unstructured":"Heath K, Hill A. WHO Hepatitis C elimination targets: the global equity challenge. Lancet Gastroenterol Hepatol. 2024;9:1\u20133. https:\/\/doi.org\/10.1016\/s2468-1253(23)00408-9.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"299_CR7","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S2468-1253(17)30249-2","volume":"2","author":"MW Sonderup","year":"2017","unstructured":"Sonderup MW, et al. Hepatitis C in sub-saharan Africa: the current status and recommendations for achieving elimination by 2030. Lancet Gastroenterol Hepatol. 2017;2(12):910\u20139. https:\/\/doi.org\/10.1016\/S2468-1253(17)30249-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"299_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0145-y","volume":"12","author":"AA Mokdad","year":"2014","unstructured":"Mokdad AA, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12(1):1\u201324.https:\/\/doi.org\/10.1186\/s12916-014-0145-y.","journal-title":"BMC Med"},{"issue":"7","key":"299_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1473-3099(15)00006-7","volume":"15","author":"VB Rao","year":"2015","unstructured":"Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV co-infection in sub-saharan Africa: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(7):819\u201324. https:\/\/doi.org\/10.1016\/S1473-3099(15)00006-7.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"299_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/jvh.12481","volume":"23","author":"J Riou","year":"2016","unstructured":"Riou J, et al. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. J Viral Hepat. 2016;23(4):244\u201355. https:\/\/doi.org\/10.1111\/jvh.12481.","journal-title":"J Viral Hepat"},{"key":"299_CR11","doi-asserted-by":"publisher","unstructured":"Cooke GS, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4(2):135\u201384.https:\/\/doi.org\/10.1016\/S2468-1253(18)30270-X.","DOI":"10.1016\/S2468-1253(18)30270-X"},{"key":"299_CR12","doi-asserted-by":"publisher","unstructured":"Palayew A, Razavi H, Hutchinson SJ, Cooke GS, Lazarus JV. Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C? Lancet Gastroenterol Hepatol. 2020;5(10):948\u2013953. https:\/\/doi.org\/10.1016\/S2468-1253(20)30011-X","DOI":"10.1016\/S2468-1253(20)30011-X"},{"key":"299_CR13","doi-asserted-by":"publisher","unstructured":"Schiavo JH. PROSPERO: An International Register of Systematic Review Protocols, Med Ref Serv Q.2019; 38(2):171\u2013180.https:\/\/doi.org\/10.1080\/02763869.2019.1588072","DOI":"10.1080\/02763869.2019.1588072"},{"key":"299_CR14","doi-asserted-by":"publisher","unstructured":"Page MJ et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"299_CR15","unstructured":"Checklist for Systematic Reviews and Research Syntheses Critical Appraisal Checklist for Systematic. Reviews Res Syntheses 2, 2017."},{"key":"299_CR16","unstructured":"R. The R Project for Statistical Computing. Accessed: Mar. 05, 2024. [Online]. Available: https:\/\/www.r-project.org\/"},{"key":"299_CR17","doi-asserted-by":"publisher","unstructured":"Kulinskaya E, Dollinger MB. An accurate test for homogeneity of odds ratios based on Cochran\u2019s Q-statistic. BMC Med Res Methodol. 2015;15(1):1\u201319. https:\/\/doi.org\/10.1186\/S12874-015-0034-X\/FIGURES\/16.","DOI":"10.1186\/S12874-015-0034-X\/FIGURES\/16"},{"key":"299_CR18","unstructured":"Jelangat M, Karoney A, Koskei Z, Rugut F, Faraj, Gardner A. Sero-prevalence of hepatitis B virus, hepatitis c virus and human immunodeficiency virus infections among blood donors in Western Kenya: A cross sectional study. East Afr Med J.Dec. 2018; 95(12): 2181\u20132188"},{"issue":"4","key":"299_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4314\/eamj.v81i4.9152","volume":"81","author":"JO Atina","year":"2004","unstructured":"Atina JO, Ogutu EO, Hardison WG, Mumo J. Prevalence of hepatitis A, B, C and human immunodeficiency virus seropositivity among patients with acute icteric hepatitis at the Kenyatta National Hospital, Nairobi. East Afr Med J. 2004;81(4):183\u20137. https:\/\/doi.org\/10.4314\/eamj.v81i4.9152.","journal-title":"East Afr Med J"},{"key":"299_CR20","unstructured":"Muchiri I, Okoth FA, Ngaira J, Tuei S. Seroprevalence of HAV, HBV, HCV, and HEV among acute hepatitis patients at Kenyatta National Hospital in Nairobi, Kenya. East Afr Med J. 89(6):199\u2013205."},{"key":"299_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4314\/eamj.v85i7.9649","volume":"85","author":"T Muasya","year":"2008","unstructured":"Muasya T, et al. Prevalence of hepatitis C virus and its genotypes among a cohort of drug users in Kenya. East Afr Med J. 2008;85:318\u201325. https:\/\/doi.org\/10.4314\/eamj.v85i7.9649.","journal-title":"East Afr Med J"},{"issue":"6","key":"299_CR22","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.4269\/ajtmh.17-0830","volume":"98","author":"TE Ly","year":"2018","unstructured":"Ly TE, Kim KN, Drobeniuc AA, Kodani J, Montgomery M, Fields JM. The prevalence of hepatitis c virus antibody in HIV-Negative persons in Kenya, 2007. Am J Trop Med Hyg. 2018;98(6):1876\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"299_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4102\/sajhivmed.v19i1.737","volume":"19","author":"C Micah. Oyaro","year":"2018","unstructured":"Oyaro M, Wylie J, Chen CY, Ondondo RO, Kramvis A. Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities. South Afr J HIV Med. 2018;19(1):1\u20139. https:\/\/doi.org\/10.4102\/sajhivmed.v19i1.737.","journal-title":"South Afr J HIV Med"},{"key":"299_CR24","doi-asserted-by":"publisher","unstructured":"Akiyama MJ, Cleland CM, Lizcano JA, Cherutich P, Kurth AE. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study. Lancet Infect Dis.Nov. 2019 19(11):1255\u20131263.https:\/\/doi.org\/10.1016\/S1473-3099(19)30264-6","DOI":"10.1016\/S1473-3099(19)30264-6"},{"key":"299_CR25","doi-asserted-by":"publisher","unstructured":"Loarec A et al. Feb., Extremely low hepatitis C prevalence among HIV co-infected individuals in four countries in sub-Saharan Africa. Aids 2019;33(2):353\u2013355.https:\/\/doi.org\/10.1097\/QAD.0000000000002070","DOI":"10.1097\/QAD.0000000000002070"},{"issue":"3","key":"299_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.15406\/jhvrv.2020.08.00225","volume":"8","author":"AK Maiyo","year":"2020","unstructured":"Maiyo AK, Odari EO, Kinyua J, Songok EM. Sero-prevalence and genotypes of hepatitis c among people who inject drugs in Nairobi Kenya. J Hum Virol Retrovirol. 2020;8(3):86\u201392. https:\/\/doi.org\/10.15406\/jhvrv.2020.08.00225.","journal-title":"J Hum Virol Retrovirol"},{"key":"299_CR27","doi-asserted-by":"publisher","unstructured":"Njeru DG, Mwanda WO, Kitonyi GW, Njagi EC. Prevalence of cytomegalovirus antibodies in blood donors at the National Blood Transfusion Centre, Nairobi., East Afr Med J. 2009;86(12):58\u201361.https:\/\/doi.org\/10.4314\/eamj.v86i12.62903","DOI":"10.4314\/eamj.v86i12.62903"},{"key":"299_CR28","doi-asserted-by":"publisher","unstructured":"Kerubo G et al. Jun., Hepatitis B, hepatitis C and HIV-1 coinfection in two informal urban settlements in Nairobi, Kenya.PLoS One. 2015;10(6):1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0129247","DOI":"10.1371\/journal.pone.0129247"},{"key":"299_CR29","unstructured":"Wairimu KM, Herbert K, John M. Prevalence of Transfusion Transmissible Infections Among Blood Donated At Nyeri Satellite Transfusion Centre In Kenya Kamande Magdaline Wairimu.Kibebe Herbert and Mokua John. 2016;6(2):20\u201330."},{"key":"299_CR30","doi-asserted-by":"publisher","unstructured":"Wamamba D et al. Nov., Transfusion transmissible infections among walk-in blood donors at Kisumu regional blood transfusion centre, Kisumu County, Kenya, 2015, Lab Medicine. 2017;48(4):362\u2013366. https:\/\/doi.org\/10.1093\/labmed\/lmx059","DOI":"10.1093\/labmed\/lmx059"},{"issue":"1","key":"299_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3276-y","volume":"11","author":"CG Onyango","year":"2018","unstructured":"Onyango CG, et al. Seroprevalence and determinants of transfusion transmissible infections among voluntary blood donors in Homabay, Kisumu and Siaya counties in western Kenya. BMC Res Notes. 2018;11(1):1\u20136. https:\/\/doi.org\/10.1186\/s13104-018-3276-y.","journal-title":"BMC Res Notes"},{"key":"299_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.11604\/pamj.2019.34.31.17885","volume":"34","author":"G Bartonjo","year":"2019","unstructured":"Bartonjo G, Oundo J, Ng\u2019ang\u2019a Z. Prevalence and associated risk factors of transfusion transmissible infections among blood donors at regional blood transfusion center nakuru and tenwek mission hospital, Kenya. Pan Afr Med J. 2019;34:1\u201313. https:\/\/doi.org\/10.11604\/pamj.2019.34.31.17885.","journal-title":"Pan Afr Med J"},{"key":"299_CR33","doi-asserted-by":"publisher","unstructured":"Harania RS, Karuru J, Nelson M, Stebbing J. HIV, Hepatitis B and Hepatitis C coinfection in Kenya. Aids. 2008;22(10):1221\u20132. https:\/\/doi.org\/10.1097\/QAD.0b013e32830162a8.","DOI":"10.1097\/QAD.0b013e32830162a8"},{"issue":"1","key":"299_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-6-363","volume":"6","author":"BM Muriuki","year":"2013","unstructured":"Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA. Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Res Notes. 2013;6(1):1\u20136. https:\/\/doi.org\/10.1186\/1756-0500-6-363.","journal-title":"BMC Res Notes"},{"key":"299_CR35","doi-asserted-by":"publisher","unstructured":"Wambani N, Ogola RJ, Makori PE AW and, DW BM, Lihana R, Hepatitis B, Co-Infections C. among HIV-1 Infected Patients Attending the Academic Model Providing Access to Healthcare Clinic, Kenya, 2014.Journal of Infectious Diseases and Diagnosis.2016; 1(1): 1\u20134.https:\/\/doi.org\/10.4172\/2576-389x.1000102","DOI":"10.4172\/2576-389x.1000102"},{"issue":"2","key":"299_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.24248\/EAHRJ-D-16-00334","volume":"1","author":"DN Maina","year":"2017","unstructured":"Maina DN, Nyerere AK, Gicho RW, Mwangi JM, Lihana RW. Prevalence and factors Associated with Hepatitis B and C Co-infection among HIV-1-Infected patients in Kenya. East Afr Health Res J. 2017;1(2):73\u20139. https:\/\/doi.org\/10.24248\/EAHRJ-D-16-00334.","journal-title":"East Afr Health Res J"},{"key":"299_CR37","unstructured":"Okoth SB, Rehmani OF, Karoney MJ, Diero L, Ayuo PO, SERO PREVALENCE OF HEPATITIS B AND C VIRUSES AMONG HIV INFECTED PATIENTS IN A HIV CARE PROGRAM IN KENYA.: A CROSS SECTIONAL STUDY. 2017; 94(4):266\u201373."},{"key":"299_CR38","unstructured":"Too OW, Wamunyokoli B, Okendo F, Oketch J, Okwaro J, Lihana Wekesa A, Ogutu R. Viral Hepatitis B and Hepatitis C co-infections of HIV-1 infected patients in Kenya. East Afr Med J. 2018;95(7):1776\u201384."},{"issue":"12","key":"299_CR39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7176\/jbah\/9-12-06","volume":"9","author":"M Joseph","year":"2019","unstructured":"Joseph M, Mpoke S. Sero-Mapping of HBV, HCV, HSV2 and Syphilis Across regions in Kenya. J Biol Agric Healthc. 2019;9(12):51\u201360. https:\/\/doi.org\/10.7176\/jbah\/9-12-06.","journal-title":"J Biol Agric Healthc"},{"key":"299_CR40","unstructured":"Onyango KO, Nyamache AK, Kasera GO, Mabeya SN, Nonoh JO. Hepatitis B and C virus co-infections and genetic diversity among HIV-1 infected individuals in Siaya County, Kenya. East Afr Med J. 2021;98(2):3508\u201318."},{"issue":"2","key":"299_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.23937\/2474-3658\/1510249","volume":"8","author":"M Joseph","year":"2022","unstructured":"Joseph M, et al. What are the missed opportunities in Prevention interventions for HBV, HCV and HIV among Key populations along the Northern Transport Corridor in Kenya? J Infect Dis Epidemiol. 2022;8(2):6\u201311. https:\/\/doi.org\/10.23937\/2474-3658\/1510249.","journal-title":"J Infect Dis Epidemiol"},{"key":"299_CR42","unstructured":"Otedo AEO, Mc\u2019Ligeyo SO, Okoth FA, Kayima JK. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. South Afr Med J. 2003;93(5):380\u20134."},{"key":"299_CR43","doi-asserted-by":"publisher","unstructured":"Wanyama FM, Tauber R, Mokomba A, Nyongesa C, Blanchard V, The Burden of Hepatitis B, Hepatitis C. and Human Immunodeficiency Viruses in Ovarian Cancer Patients in Nairobi, Kenya.Infect Dis Rep. 2022;14(3):433\u2013445.https:\/\/doi.org\/10.3390\/idr14030047","DOI":"10.3390\/idr14030047"},{"issue":"4","key":"299_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1530\/EC-15-0071","volume":"4","author":"EM Ndombi","year":"2015","unstructured":"Ndombi EM, et al. Serum adiponectin in HIV-1 and Hepatitis C virus mono- and coinfected Kenyan injection drug users. Endocr Connect. 2015;4(4):223\u201332. https:\/\/doi.org\/10.1530\/EC-15-0071.","journal-title":"Endocr Connect"},{"key":"299_CR45","doi-asserted-by":"publisher","unstructured":"Mwatelah RS, et al. Co-infection burden of hepatitis C virus and human immunodeficiency virus among injecting heroin users at the Kenyan coast. PLoS ONE. 2015;10(7):1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0132287.","DOI":"10.1371\/journal.pone.0132287"},{"key":"299_CR46","doi-asserted-by":"publisher","unstructured":"Sambai BC et al. Dec., Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.BMC Infect Dis. 2022;22(1):1\u201315.https:\/\/doi.org\/10.1186\/s12879-022-07036-8","DOI":"10.1186\/s12879-022-07036-8"},{"key":"299_CR47","doi-asserted-by":"publisher","unstructured":"Sterne professor JAC, Sutton professor AJ. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials, https:\/\/doi.org\/10.1136\/bmj.d4002","DOI":"10.1136\/bmj.d4002"},{"key":"299_CR48","doi-asserted-by":"publisher","unstructured":"Salari N, Kazeminia M, Hemati N, Ammari-Allahyari M, Mohammadi M, Shohaimi S. Global prevalence of hepatitis C in general population: A systematic review and meta-analysis, Travel Med Infect Dis, vol. 46, no. April 2021, p. 102255, 2022, https:\/\/doi.org\/10.1016\/j.tmaid.2022.102255","DOI":"10.1016\/j.tmaid.2022.102255"},{"issue":"1","key":"299_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1584-1","volume":"16","author":"N Mora","year":"2016","unstructured":"Mora N, et al. A synthesis of Hepatitis C prevalence estimates in Sub-saharan Africa: 2000\u20132013. BMC Infect Dis. 2016;16(1):1\u20138. https:\/\/doi.org\/10.1186\/s12879-016-1584-1.","journal-title":"BMC Infect Dis"},{"key":"299_CR50","doi-asserted-by":"publisher","unstructured":"Mwangi J, et al. Hepatitis C virus genotypes in Kenya. Arch Virol. 2016;161(1):95\u2013101. https:\/\/doi.org\/10.1007\/S00705-015-2623-8\/FIGURES\/1.","DOI":"10.1007\/S00705-015-2623-8\/FIGURES\/1"},{"key":"299_CR51","doi-asserted-by":"publisher","unstructured":"Anejo-Okopi J, Okojokwu OJ, Audu O, Virus HC. Molecular Epidemiology, Treatment and Diagnosis Challenges in Sub-Saharan Africa (SSA).Hosts and Viruses. 2020;7(3).https:\/\/doi.org\/10.17582\/journal.hv\/2020\/7.3.43.49","DOI":"10.17582\/journal.hv\/2020\/7.3.43.49"},{"key":"299_CR52","doi-asserted-by":"publisher","unstructured":"Makokha GN, Zhang P, Hayes CN, Songok E, Chayama K. The burden of Hepatitis B virus infection in Kenya: a systematic review and meta-analysis. Front Public Health.2023;11. https:\/\/doi.org\/10.3389\/FPUBH.2023.986020\/FULL.","DOI":"10.3389\/FPUBH.2023.986020\/FULL"},{"key":"299_CR53","doi-asserted-by":"publisher","unstructured":"Downs LO, et al. A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: data to inform clinical care and health policy. PLOS Global Public Health. 2023;3(1):e0001165. https:\/\/doi.org\/10.1371\/JOURNAL.PGPH.0001165.","DOI":"10.1371\/JOURNAL.PGPH.0001165"},{"key":"299_CR54","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.3748\/wjg.v24.i34.3927","volume":"24","author":"MA Hassan-Kadle","year":"2018","unstructured":"Hassan-Kadle MA, Osman MS, Ogurtsov PP. Epidemiology of viral hepatitis in Somalia: systematic review and meta-analysis study. World J Gastroenterol. 2018;24:3927\u201357. https:\/\/doi.org\/10.3748\/wjg.v24.i34.3927.","journal-title":"World J Gastroenterol"},{"key":"299_CR55","unstructured":"Kenya\u2019s Dadaab struggles with new influx of Somalis fleeing drought| UNHCR. Accessed: Apr. 09, 2024. [Online]. Available: https:\/\/www.unhcr.org\/news\/stories\/kenya-s-dadaab-struggles-new-influx-somalis-fleeing-drought"},{"key":"299_CR56","doi-asserted-by":"publisher","unstructured":"Kim MH, Kang SY, Lee WI, Lee MY. Evaluation of HCV RNA by PCR and signal-to-cutoff ratios of HCV antibody assays for diagnosis of HCV infection. Lab Med. 2021;52(3):240\u20134. https:\/\/doi.org\/10.1093\/LABMED\/LMAA074.","DOI":"10.1093\/LABMED\/LMAA074"},{"key":"299_CR57","doi-asserted-by":"publisher","unstructured":"Seeff LB. Natural history of chronic hepatitis C, Hepatology. 2002;36(5) Suppl 1. https:\/\/doi.org\/10.1053\/JHEP.2002.36806","DOI":"10.1053\/JHEP.2002.36806"},{"key":"299_CR58","doi-asserted-by":"publisher","unstructured":"Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: results from a nationwide survey, J Viral Hepat. 2012;19(8):560\u2013567. https:\/\/doi.org\/10.1111\/J.1365-2893.2011.01576.X","DOI":"10.1111\/J.1365-2893.2011.01576.X"},{"key":"299_CR59","doi-asserted-by":"publisher","unstructured":"Mohammadi M, et al. Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients. Virol J. 2009;6. https:\/\/doi.org\/10.1186\/1743-422X-6-202.","DOI":"10.1186\/1743-422X-6-202"},{"key":"299_CR60","doi-asserted-by":"publisher","unstructured":"Mwaniki SW, Kaberia PM, Mugo PM, Palanee-Phillips T. HIV prevalence and associated risk factors among young tertiary student men who have sex with men (MSM) in Nairobi, Kenya: a respondent-driven sampling survey.AIDS Res Ther. 2023;20(1): 1\u201311.https:\/\/doi.org\/10.1186\/S12981-023-00502-6\/TABLES\/2","DOI":"10.1186\/S12981-023-00502-6\/TABLES\/2"},{"key":"299_CR61","doi-asserted-by":"publisher","unstructured":"Parker E, et al. HIV infection in Eastern and Southern Africa: highest burden, largest challenges, greatest potential. South Afr J HIV Med. 2021;22(1). https:\/\/doi.org\/10.4102\/SAJHIVMED.V22I1.1237.","DOI":"10.4102\/SAJHIVMED.V22I1.1237"},{"key":"299_CR62","doi-asserted-by":"publisher","unstructured":"Artenie A, et al. Incidence of HIV and Hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):533\u201352. https:\/\/doi.org\/10.1016\/S2468-1253(23)00018-3.","DOI":"10.1016\/S2468-1253(23)00018-3"},{"key":"299_CR63","doi-asserted-by":"publisher","unstructured":"Ludwig-Barron NT, et al. Barriers and facilitators of HIV and Hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators. Harm Reduct J. 2021;18(1):133. https:\/\/doi.org\/10.1186\/S12954-021-00580-7.","DOI":"10.1186\/S12954-021-00580-7"},{"issue":"1","key":"299_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7448\/IAS.19.1.20711","volume":"19","author":"TCL Azevedo","year":"2016","unstructured":"Azevedo TCL, Zwahlen M, Rauch A, Egger M, Wandeler G. Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in Africa. J Int AIDS Soc. 2016;19(1):1\u20138. https:\/\/doi.org\/10.7448\/IAS.19.1.20711.","journal-title":"J Int AIDS Soc"},{"key":"299_CR65","doi-asserted-by":"publisher","unstructured":"Melikoki V, Kourlaba G, Kanavaki I, Fessatou S, Papaevangelou V. Seroprevalence of Hepatitis C in Children without identifiable Risk-Factors: a systematic review and Meta-analysis. J Pediatr Gastroenterol Nutr. 2021;72(6):E140\u20138. https:\/\/doi.org\/10.1097\/MPG.0000000000003099.","DOI":"10.1097\/MPG.0000000000003099"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00299-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-024-00299-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-024-00299-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T10:16:02Z","timestamp":1727691362000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-024-00299-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":65,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["299"],"URL":"https:\/\/doi.org\/10.1007\/s44197-024-00299-1","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"23 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this is a systematic review and meta-analysis of published literature, ethical approval was not sought.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}